Practice Guideline Recommendations: Disease-modifying Therapies for Adults with Multiple Sclerosis - AAN | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
AAN
2024
·
USA
·
Neurology
Practice Guideline Recommendations: Disease-modifying Therapies for Adults with Multiple Sclerosis
Document
Analyser ce document